Phase-3 trial of recombinant human alkaline phosphatase for patients with sepsis-associated acute kidney injury (REVIVAL)Peter Pickkers, Juliane Bernholz, Morten H. Bestle et al.|Intensive Care Medicine|2024Cited by 67
Study protocol of a randomised, double-blind, placebo-controlled, two-arm parallel-group, multi-centre phase 3 pivotal trial to investigate the efficacy and safety of recombinant human alkaline phosphatase for treatment of patients with sepsis-associated acute kidney injuryPeter Pickkers, Anne Louise Kjølbye, Derek C. Angus et al.|BMJ Open|2023Cited by 17
Phase 3 Trial of Recombinant Human Alkaline Phosphatase for Patients with Sepsis-Associated Acute Kidney Injury (REVIVAL)Peter Pickkers, Alexander Zarbock, Derek C. Angus et al.|Research Square|2023Cited by 8